TSVT Stock Summary and Trading Ideas (2Seventy Bio | NASDAQ:TSVT)

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.

2Seventy Bio trades on the NASDAQ stock market under the symbol TSVT.

As of December 12, 2024, TSVT stock price declined to $3.34 with 341,381 million shares trading.

TSVT has a beta of 3.29, meaning it tends to be more sensitive to market movements. TSVT has a correlation of 0.16 to the broad based SPY ETF.

TSVT has a market cap of $172.31 million. This is considered a Micro Cap stock.

Last quarter 2Seventy Bio reported $14 million in Revenue and -$.19 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.05.

In the last 3 years, TSVT traded as high as $33.25 and as low as $1.54.

The top ETF exchange traded funds that TSVT belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.

TSVT has underperformed the market in the last year with a price return of +3.4% while the SPY ETF gained +32.3%. TSVT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -25.8% and -15.7%, respectively, while the SPY returned +9.3% and +0.9%, respectively.

TSVT support price is $3.50 and resistance is $3.96 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TSVT shares will trade within this expected range on the day.